Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 229-235

  Filion, M C ^a,b   Lepicier P ^a   Morales, A ^c   Phillips, N C ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Bioniche Inc   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Apoptosis; Bladder cancer cells; Granulocyte macrophage colony stimulating factor interleukin 6; Interleukin 12; Mycobacterial cell wall

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL DNA; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 6; MYCOBACTERIAL CELL COMPLEX; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL CELL WALL; BLADDER CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DEGRADATION; DRUG MECHANISM; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MYCOBACTERIUM PHLEI; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0032894696     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690038     Document Type: Article

References (50)

1. Alexandroff AG, Black J, Esuvaranathan K and James K (1997) Antiproliferative effect of IL-6 on transitional cell carcinoma of the bladder. Insight into mechanisms of bacillus Calmette-Guérin in immunotherapy. Biochem Soc Trans 25: 270S
2. Bevers RF, de Boer EC, Kruth LH and Schamhart DH (1997) Effects of isoniazid on the proliferation and cytokine production of bladder cancer cells in vitro induced by bacille Calmette-Guérin. Br J Urol 80: 35-39
3. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF and Gately MK (1993) Antitumour and antimetastatic activity of interleukin-12 against murine tumors. J Exp Med 178: 1223-1230
4. Chen L, Chen D, Block E, O'Donnell M, Kufe DW and Clinton SK (1997) Eradication of murine bladder carcinoma by intratumoral injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J Immunol 159: 351-359
5. Chin JL, Kadhim SA, Batislam E, Karlik SJ, Garcia BM, Curtis Nickel J and Morales A (1996) Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer. J Urol 156: 1189-1193
6. De Reijke TM, Vos PC, de Boer EC, Bevers RF, de Munick Keizer, Kurth KH and Schambart DH (1993) Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG). Urol Res 21: 349-352
7. Dive C, Evans CA and Whetton AD (1992) Induction of apoptosis: new targets for cancer chemotherapy. Semin Cancer Biol 3: 417-427
8. El-Demiry MIM, Hargreave TB, Busuttil A, James K and Chrisholm GD (1986) Immunohistochemical identification of lymphocyte subsets and macrophages in normal human urothelium using monoclonal antibodies, Br J Urol 58: 436-442
9. Esuvaranathan K, Alexandroff AG, McIntyre M, Jackson AM, Prescott S, Chisholm GD and James K (1995) Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. J Urol 154: 572-575
10. Filion MC and Phillips NC (1997) Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta 1329: 345-356
11. Filion MC, Lépicier P and Phillips NC (1997) Mycobacterium phlei cell wall complex, a new antitumoral agent, induces IL-12 synthesis by monocytes/macrophages. Blood 90: 58b
12. Filion MC et al (1998) (manuscript in preparation)
13. Hawkyard SJ, Jackson AM, Prescott S, James K and Chisholm GD (1993) The effect of recombinant cytokines on bladder cancer cells in vitro. J Urol 150: 514-518
14. Ioachim-Velogianni E, Stavropoulos NE, Kitsiou E, Stefanaki S and Agnantis NJ (1994) HLA-DR antigen expression subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study in frozen sections. J Pathol 174: 183-189
15. Izquierdo MA, Degen D, Sypek JP and Von Hoff DD (1996) Antiproliferative effects of IL-12 on human tumor colony-forming units taken directly from patients. Anticancer Drugs 7: 275-280
16. Jackson AM, Alexandroff AB, Fleming D, Prescott S, Chisholm GD, Carter GD and James K (1994) Bacillus Calmette-Guérin (BCG) organisms directly alter the growth of bladder tumour cells. Int J Oncol 5: 697-703
17. Kadhim SA, Chin JL, Batislam E, Karlick S, Garcia BM, Curtis Nickel J and Morales A (1993) Modification of intravesical Bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder tumor: use of mycobacterial cell wall extract (MCWE). J Urol 149: A225
18. Kawasaki T, Tomila Y, Bilim V, Takeda M, Takahashi K and Kumanishi T (1996) Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations. Int J Cancer 68: 501-505
19. Kudoh S, Liu XX, Mori K and Suzuki T (1997) BCG-activated lymphocytes induce the death of bladder cancer cell via apoptosis in vitro. Br J Urol 80S2: 40
20. Lagranderie MRR, Balazue A-M, Deriaud E, Leclerc CD and Gheorghiu M (1996) Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immunol 64: 1-9
21. Lamm DL (1995) BCG in perspective: advances in the treatment of superficial bladder cancer. Eur Urol 27S1: 2
22. Lamm DL, van der Meijden AD and Morales A (1992) Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in supperficial bladder cancer. J Urol 147: 596-600
23. Lamm DL, Riggs DR, Traynelis CL and Nseyo UN (1995) Failure of intravesical chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder. J Urol 153: 1444-1450
24. Mallick BB, Kishore S, Das SK and Garg A (1985) Non-specific immunostimulation against viruses. Comp Immunol Microbiol Infect Dis 8: 55-63
25. Miller T, Beausang LA, Meneghini M and Lidgard G (1993) Death-induced changes to the nuclear matrix: the use of anti-nuclear matrix antibodies to study agents of apoptosis. Biotechniques 15: 1042-1047
26. Mizutani Y, Okada Y, Yoshida O, Fukumoto M and Bonavida B (1997) Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity. Cancer 79: 1180-1189
27. Morales A (1984) Long term results of BCG therapy for bladder cancer. J Urol 132: 457-459
28. Morales A and Chin JL (1997) Mycobacterial cell wall (MCW) as an alternative to BCG in the treatment of carcinoma-in-situ (CIS) of bladder: an efficacy study. J Urol 157: A214
29. Mosman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63
30. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Stewart WT, Storkus J and Lotze MT (1994) Recombinant interleukin-12 (IL-12) administration induces tumor regression in association with interferon-γ production. J Immunol 153: 1697-1706
31. Newell MK, Haughn LJ, Maroun CR and Julius MH (1990) Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347: 286-288
32. Noguchi Y, Richards EC, Chen YT and Old LJ (1995) Influence of interleukin-12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci USA 92: 2219-2223
33. Okamoto M, Hattori K and Oyasu R (1997) Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 72: 149-154
34. Papapetropoulou M, Tsintzou A and Vantarakis A (1997) Environmental mycobacteria in bottled table waters in Greece. Can J Microbiol 43: 499-502
35. Phillips NC, Gagné L, Ivanoff N and Riveau G (1996) Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine 14: 898-904
36. Pryor K, Stricker P, Russell P, Golovsky D and Penny R (1995a) Antiproliferative effects of bacillus Calmette-Guérin and interferon α2b on human bladder cancer cells in vitro. Cancer Immunol Immunother 41: 309-316
37. Pryor K, Goddard J, Goldstein D, Stricker P, Russell P, Govolsky D and Penny R (1995b) Bacillus Calmette-Guérin (BCG) enhances monocyte-and lymphocyte-mediated bladder tumour cell killing. Br J Cancer 71: 801-807
38. Rahman M (1994) In vitro effects of high energy shock wave alone and combined with anticancer drugs on human bladder cancer cells. Urol Int 53: 12-17
39. Rasheed S, Gardner MB, Rongey RW, Nelson-Rees A and Arnstein P (1977) Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst 58: 881-887
40. Sasaki A, Kudoh S, Mori K, Takahashi N and Suzuki T (1997) Are BCG effects against urinary bladder carcinoma cell line T24 correlated with apoptosis in vitro? Urol Int 59: 142-148
41. Shemtov MM, Cheng DL-W, Kong L, Shu W-P, Sassaroli M, Droller MJ and Liu BC-S (1995) LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BGC therapy. J Urol 154: 269-274
42. Stern AS, Magram J and Presky DH (1996) Interleukin-12 an integral cytokine in the immune response. Life Sci 58: 639-654
43. Stine KC, Warren BA and Becton DL (1996) Apoptosis induced by interleukin-12 measured by DNA electrophoresis and in situ end labelling in leukemia. Ann NY Acad Sci 795: 420-421
44. Tewari AK, Sharma NN, Rao JR, Mishra AK and Das SK (1996) Effect of Mycobacterium phlei on the development of immunity to Babesia bigemina. Ver Parasitol 62: 223-230
45. Voest EE, Kenyon MN, O'Reilly MS, Truitt G, D'Amato RJ and Folkman J (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87: 581-586
46. Wyllie SH (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306
47. Zitvogel L and Lotze NH (1995) Role of interleukin-12 (IL-12) as an anti-tumor agent: experimental biology and clinical application. Res Immunol 146: 628-638
48. Zlotta AR, Drowart A, Huygen K, De Bruyn J, Shekarsarai H, Decock M, Pirson M, Jurion F, Palfliet K, Denis O, Mascart F, Simon J, Schulman CC and Van Vooren JP (1997a) Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer. Clin Exp Immunol 109: 157-165
49. Zlotta AR, Drowart A, Van Vorren JP, de Cook M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC and Huygen K (1997b) Evaluation and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guérin during intravesical treatment of superficial bladder cancer. J Urol 157: 492-498
50. Zou JP, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H and Hamaoka T (1995) Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed interferon-γ production by anti-tumor T cells. Int Immunol 7: 1135-1145